The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer
Autor: | Yan-Xing Chen, Huai-Qiang Ju, Zhan-Hong Chen, Jia-jia Hu, Rui-Hua Xu, Ying-Nan Wang, Jia-huan Lu, Hui Sheng, Yun Wang, Kai Yu, Pei-Shan Hu, Zexian Liu, Jia-Bo Zheng, Hai-Yu Mo, Qi-Nian Wu, Dong-dong Yang, Zhao-Lei Zeng |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
Cancer Research Epithelial-Mesenchymal Transition Colorectal cancer Mice Nude Antineoplastic Agents Cell Cycle Proteins colorectal cancer Biology chemotherapeutic sensitivity Real-Time Polymerase Chain Reaction lcsh:RC254-282 Metastasis Mice Cell Line Tumor microRNA medicine Animals Humans Radiology Nuclear Medicine and imaging Neoplasm Metastasis Tumor Stem Cell Assay Aged Cell Proliferation Original Research Cancer Biology Mice Inbred BALB C miR‐125b‐2‐3p drug resistance Competing endogenous RNA Cell growth Middle Aged Protein-Tyrosine Kinases HCT116 Cells medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Long non-coding RNA digestive system diseases Up-Regulation MicroRNAs Wee1 Oncology Drug Resistance Neoplasm Cancer research biology.protein Female RNA Long Noncoding XIST Colorectal Neoplasms |
Zdroj: | Cancer Medicine, Vol 10, Iss 7, Pp 2423-2441 (2021) Cancer Medicine |
ISSN: | 2045-7634 |
Popis: | Background Numerous reports on microRNAs have illustrated their role in tumor growth and metastasis. Recently, a new prognostic factor, miR‐125b‐2‐3p, has been identified for predicting chemotherapeutic sensitivity in advanced colorectal cancer (CRC). However, the specific mechanisms and biological functions of miR‐125b‐2‐3p in advanced CRC under chemotherapy have yet to be elucidated. Methods MiR‐125b‐2‐3p expression was detected by real‐time PCR (RT‐PCR) in CRC tissues. The effects of miR‐125b‐2‐3p on the growth, metastasis, and drug sensitivity of CRC cells were tested in vitro and in vivo. Based on multiple databases, the upstream competitive endogenous RNAs (ceRNAs) and the downstream genes for miR‐125b‐2‐3p were predicted by bioinformatic analysis, followed by the experiments including luciferase reporter assays, western blot assays, and so on. Results MiR‐125b‐2‐3p was significantly lowly expressed in the tissues and cell lines of CRC. Higher expression of miR‐125b‐2‐3p was associated with relatively lower proliferation rates and fewer metastases. Moreover, overexpressed miR‐125b‐2‐3p remarkably improved chemotherapeutic sensitivity of CRC in vivo and in vitro. Mechanistically, miR‐125b‐2‐3p was absorbed by long noncoding RNA (lncRNA) XIST regulating WEE1 G2 checkpoint kinase (WEE1) expression. The upregulation of miR‐125b‐2‐3p inhibited the proliferation and epithelial‐mesenchymal transition (EMT) of CRC induced by lncRNA XIST. Conclusions Lower miR‐125b‐2‐3p expression resulted in lower sensitivity of CRC to chemotherapy and was correlated with poorer survival of CRC patients. LncRNA XIST promoted CRC metastasis acting as a ceRNA for miR‐125b‐2‐3p to mediate WEE1 expression. LncRNA XIST‐miR‐125b‐2‐3p‐WEE1 axis not only regulated CRC growth and metastasis but also contributed to chemotherapeutic resistance to CRC. Low expression of miR‐125b‐2‐3p in CRC was linked to lower chemotherapeutic sensitivity and poor survival. The lncRNA XIST promoted CRC invasion and migration by functioning as a ceRNA for miR‐125b‐2‐3p to mediate WEE1 expression. Our findings suggest that the lncRNA XIST‐miR‐125b‐2‐3p‐WEE1 axis not only regulated CRC growth and metastasis but also contributed to chemotherapeutic resistance to CRC, which may shed light on their targeted applications. |
Databáze: | OpenAIRE |
Externí odkaz: |